13F-HR filed by Merck & Co., Inc.
Merck & Co., Inc. filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 13 holding rows worth $258,037,542.
- Accession
- 0000895345-25-000055
- Filer
- CIK 310158
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 13 entries on the cover page, a total value of $258,037,542 stated on the cover page (in dollars after the unit check, H1), rows summing to $258,037,542 with VALUE read as dollars as filed, 13F file number 028-25193. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerMERCK SHARP & DOHME LLC
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MODERNA INC | 60770K107 | COM | 2,308,190 | $95,974,540 | dollars as filed | |
| PERSONALIS INC | 71535D106 | COMMON STOCK | 14,044,943 | $81,179,771 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 772,165 | $31,064,198 | dollars as filed | |
| ENTRADA THERAPEUTICS INC | 29384C908 | COM | 1,739,768 | $30,080,589 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 3,545,719 | $6,701,409 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 2,723,509 | $5,011,257 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 998,163 | $2,615,187 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 93,414 | $1,790,746 | dollars as filed | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 1,483,758 | $1,416,989 | dollars as filed | |
| LAVA THERAPEUTICS NV | N51517105 | SHS | 1,149,345 | $1,093,027 | dollars as filed | |
| CARISMA THERAPEUTICS INC | 14216R101 | COM | 1,473,240 | $616,993 | dollars as filed | |
| EVAXION BIOTECH A/S | 29970R204 | SPONSORED ADS | 542,279 | $458,443 | dollars as filed | |
| NEUPHORIA THERAPEUTICS INC | 64136E102 | COM | 10,027 | $34,393 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000895345-25-000055 | this filing | 2025-02-14 | acceptance time not in the bulk data set |